Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 26 studies with search of: | "Eosinophilia" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Recruiting |
Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
|
||||
2 | Completed |
L-5-HTP-Related EMS
|
||||
3 | Active, not recruiting |
Phase II Gleevec Idiopathic Hypereosinophilic Syndrome
|
||||
4 | Recruiting |
A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression
|
||||
5 | Recruiting |
Montelukast in the Treatment of Duodenal Eosinophilia
|
||||
6 | Recruiting |
Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic Disorders
|
||||
7 | Recruiting |
Imatinib Mesylate to Treat Myeloproliferative Hypereosinophilic Syndrome
|
||||
8 | Completed |
Anti-Interleukin-5 Antibody to Treat Hypereosinophilic Syndrome
|
||||
9 | Recruiting |
The Efficacy of Three Months-Prednisolone Therapy for Chronic Eosinophilic Pneumonia
|
||||
10 | Recruiting |
Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias
|
||||
11 | Recruiting |
Treatment of Hypersensitivity Syndrome (DRESS) With Tegeline® (Human Immunoglobulin)
|
||||
12 | Completed |
Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)
|
||||
13 | Active, not recruiting |
Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome
|
||||
14 | Completed |
Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes
|
||||
15 | Active, not recruiting |
The Prednisone-Sparing Effect of Anti-IL-5 Antibody (SB-240563)
|
||||
16 | Recruiting |
Data Bank for Eosinophilic Disorders
|
||||
17 | Active, not recruiting |
A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders
|
||||
18 | Active, not recruiting |
A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Blood Related Cancers
|
||||
19 | Recruiting |
Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes
|
||||
20 | Active, not recruiting |
Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)
|
Previous Page | Studies Shown (1-20) | Next (21-26) |